Clinical Trial Update: XEN1101 for Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of XEN1101 for Major Depressive Disorder has completed, indicating results suitable for further development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• XEN1101

Snippet

Sponsor: James Murrough | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED